7-27108103-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153631.3(HOXA3):c.1144C>A(p.Leu382Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,610,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_153631.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HOXA3 | NM_153631.3 | c.1144C>A | p.Leu382Ile | missense_variant | 6/6 | ENST00000612286.5 | NP_705895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HOXA3 | ENST00000612286.5 | c.1144C>A | p.Leu382Ile | missense_variant | 6/6 | 2 | NM_153631.3 | ENSP00000484411.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000810 AC: 2AN: 246812Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133876
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458264Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 724934
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2024 | The c.1144C>A (p.L382I) alteration is located in exon 4 (coding exon 2) of the HOXA3 gene. This alteration results from a C to A substitution at nucleotide position 1144, causing the leucine (L) at amino acid position 382 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at